Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina.
Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, North Carolina.
Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):652-663. doi: 10.1016/j.ijrobp.2023.04.035. Epub 2023 May 6.
Early-stage squamous cell carcinoma of the glottic larynx is commonly treated with 2-dimensional or 3-dimensional conventional radiation therapy (CRT). Despite its use in other head and neck cancers, intensity-modulated radiation therapy (IMRT) remains controversial in this patient population.
A systematic review was performed by querying 3 databases (Pubmed, Embase, Web of Science) for articles published between December 1, 2000 and September 2, 2022. Included studies reported outcomes in at least 10 patients treated with IMRT for early-stage glottic cancer. Data were extracted and reported following PRISMA standards. Pooled outcomes were estimated using random-effects models. Primary outcome was the rate of local failure (LF) following IMRT. Secondary outcomes included rates of regional failure (RF) following IMRT and rates of LF and RF following CRT.
A total of 15 studies (14 retrospective, 1 prospective) consisting of 2083 patients were identified. IMRT was used in 873 patients (64% T1, 28% T2). Multiple treatment (partial larynx, single vocal cord carotid sparing) and image-guided radiation therapy techniques were used. The pooled crude rate of LF was 7.6% (95% confidence inverval [CI], 3.6%-11.5%) and actuarial LF rates at 3 and 5 years were 6.3% (95% CI, 2.2%-10.3%) and 9.0% (95% CI, 4.4%-13.5%), respectively. The pooled crude rate of RF after IMRT was 1.5% (95% CI, 0.5%-2.5%). On metaregression analysis, increased rate of LF was significantly associated with T2 disease (P < .001) and grade 2 to 3 histology (P < .001). Treatment with CRT was reported in 738 patients (76% T1, 22% T2). Among the studies reporting outcomes of both modalities, there was no significant difference in LF (log odds ratio; P = .12) or RF (log odds ratio; P = .58) between IMRT or CRT.
In patients with early-stage glottic cancer, retrospective data suggests local and regional control are similar for patients treated with IMRT and CRT. Additional prospective studies with uniform methods of volume delineation and image guidance are needed to confirm the efficacy of IMRT.
早期声门型喉鳞状细胞癌通常采用二维或三维常规放射治疗(CRT)治疗。尽管调强放射治疗(IMRT)已用于其他头颈部癌症,但在该患者人群中仍存在争议。
通过查询 3 个数据库(Pubmed、Embase、Web of Science),对 2000 年 12 月 1 日至 2022 年 9 月 2 日期间发表的文章进行了系统回顾。纳入的研究报告了至少 10 例接受 IMRT 治疗早期声门型癌症患者的结果。按照 PRISMA 标准提取和报告数据。使用随机效应模型估计汇总结果。主要结局是 IMRT 后局部失败(LF)的发生率。次要结局包括 IMRT 后区域失败(RF)的发生率以及 CRT 后 LF 和 RF 的发生率。
共确定了 15 项研究(14 项回顾性研究,1 项前瞻性研究),共纳入 2083 例患者。873 例患者接受了 IMRT(64% T1,28% T2)。使用了多种治疗(部分喉、单侧声带颈动脉保留)和图像引导放射治疗技术。LF 的汇总粗率为 7.6%(95%置信区间[CI],3.6%-11.5%),3 年和 5 年的累计 LF 率分别为 6.3%(95%CI,2.2%-10.3%)和 9.0%(95%CI,4.4%-13.5%)。IMRT 后 RF 的汇总粗率为 1.5%(95%CI,0.5%-2.5%)。通过荟萃回归分析,LF 率的增加与 T2 疾病(P<.001)和 2-3 级组织学(P<.001)显著相关。738 例患者接受了 CRT 治疗(76% T1,22% T2)。在报告两种治疗方式结果的研究中,IMRT 或 CRT 之间 LF(对数优势比;P=0.12)或 RF(对数优势比;P=0.58)无显著差异。
在早期声门型喉癌患者中,回顾性数据表明,接受 IMRT 和 CRT 治疗的患者局部和区域控制相似。需要进行更多具有统一容积勾画和图像引导方法的前瞻性研究,以证实 IMRT 的疗效。